サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571685

北米の在宅ヘルスケアの市場規模、シェア、動向分析レポート：コンポーネント別、適応症別、地域別、セグメント予測、2024年～2030年

North America Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Cancer), By Region And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 80 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
北米の在宅ヘルスケアの市場規模、シェア、動向分析レポート：コンポーネント別、適応症別、地域別、セグメント予測、2024年～2030年
出版日: 2024年09月20日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

北米の在宅ヘルスケア市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、北米の在宅ヘルスケア市場規模は2024年から2030年にかけてCAGR 7.7%を記録し、2030年には2,850億5,000万米ドルに達する見込みです。

高齢化人口の増加、ヘルスケア支出に充てる可処分所得の高さ、対象疾患の増加率などが成長を促進する主な要因です。慢性疾患の優位性、診断費用の増加が成長を押し上げると予測されています。

個別化された医療支援は、治療費を抑制する費用対効果の高い手段であり、業界の主要な推進力として機能します。米国の健康ランキングによると、2022年には米国に住む65歳以上の成人は約5,800万人に達します。

在宅ヘルスケア産業は、静脈うっ滞性潰瘍、糖尿病性潰瘍、褥瘡など様々な疾病に罹患しやすい膨大な高齢化人口によって大きく牽引されると予想されます。WHOによると、世界の60歳以上人口は2014年に8億4,100万人に達し、2050年には20億人に達すると予想されています。そのため、世界の高齢化率の上昇と、在宅ヘルスケア患者の約70％が65歳以上の年齢層に属するという統計が、近い将来の需要を促進すると予想されています。

創傷ケアは2014年の世界市場収益の65％を占めています。創傷閉鎖材、創傷ケア用ドレッシング材、創傷洗浄剤に対する大きな需要が、過去数年間におけるこの分野の優位性につながっており、この動向は予測期間中も続くと予想されます。創傷感染は医療従事者や患者にとって安全上の重要な関心事であるため、市場は感染率の低下を余儀なくされ、需要を促進すると予想されます。創傷ケア製品は、糖尿病性潰瘍、褥瘡、静脈うっ滞性潰瘍などの様々な疾患に罹患している患者の全体的な健康を改善するため、業界ではこれらの製品に対する強いニーズを生み出しています。

個人の安全や衛生に対する意識の高まりに伴う老人患者の増加は、北米における在宅ヘルスケアサービスの需要をさらに高めると予想されます。バクスターは、ヘルスケア専門家に個別ケアを提供するための幅広いソリューションを提供しています。病院ケア、プライマリーケア、腎臓ケア、外科ケア、栄養ケアなど、ヘルスケア専門家向けの製品を提供しています。

2023年の市場シェアは、サービス分野が84.1%で最大でした。このセグメントはさらに、熟練在宅介護と非熟練在宅介護に分けられます。在宅ヘルスケアサービスでは、栄養サポート、看護ケア、ホスピス＆緩和ケア、医師によるプライマリケアなど、さまざまなサービスが提供されます。熟練したヘルスケアによって提供される正確な診断と治療が、このセグメントの成長に寄与しています。一方、機器分野は予測期間中に8.6%のCAGRを記録すると予想されています。このセグメントは治療、診断、移動補助の各セグメントに分けられます。

米国の在宅ヘルスケア市場は、高度なヘルスケアインフラを背景に、2023年には90.0％のシェアで北米市場を独占しました。高齢化人口が多いこと、ヘルスケア・インフラが整備されつつあること、購買力が高いことなどが成長を促進する主な要因です。さらに、在宅介護サービスを推進することで治療費の抑制を目指す政府のイニシアティブが成長を後押しすると予想されます。人口問題研究所（PRB）によると、北米の65歳以上の人口は現在約5,000万人で、2050年には8,900万人に達すると予測されています。

北米の在宅ヘルスケア市場レポート・ハイライト

  • 2023年の市場シェアは、サービス分野が84.1%で最大。このセグメントはさらに熟練在宅介護と非熟練在宅介護に分けられます。
  • 機器分野は予測期間中に8.6%の最速CAGRを記録する見込み。このセグメントは治療、診断、移動支援セグメントに分けられます。
  • 2023年には、糖尿病・腎障害分野が最大の市場シェアを占める。米国糖尿病協会によると、2021年に3,840万人の米国人が糖尿病と診断されました。
  • 移動障害セグメントは、予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米の在宅ヘルスケア市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 北米の在宅ヘルスケア市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 北米の在宅ヘルスケア市場：コンポーネントの推定・動向分析

  • セグメントダッシュボード
  • 北米の在宅ヘルスケア市場：コンポーネントの変動分析、2023年および2030年
  • 装置
  • サービス

第5章 北米の在宅ヘルスケア市場：適応症の推定・動向分析

  • セグメントダッシュボード
  • 北米の在宅ヘルスケア市場：適応症変動分析、2023年および2030年
  • 心血管疾患と高血圧
  • 糖尿病と腎臓疾患
  • 神経疾患および精神疾患
  • 呼吸器疾患とCOPD
  • 母体疾患
  • 運動障害
  • がん
  • 創傷ケア
  • その他

第6章 北米の在宅ヘルスケア市場：地域の推定・動向分析

  • 北米の在宅ヘルスケア市場シェア、地域別、2023年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • B. Braun SE
    • Abbott
    • Sunrise Medical
    • 3M
    • Baxter
    • Medtronic
    • Cardinal Health
    • F. Hoffmann-La Roche Ltd
    • Amedisys
    • ARKRAY, Inc.
    • BD
    • OMRON Healthcare, Inc.
    • GE Healthcare
    • Medline Industries, Inc
    • Koninklijke Philips NV
    • Johnson &Johnson Services, Inc.
    • Acelity（3M）
    • Teleflex Incorporated.
    • Fresenius Kabi AG.
    • Bayer AG
    • GF Health Products, Inc.
    • Knight Health Holdings, LLC
    • NHC, National Healthcare Corporation
    • Gentiva
    • Medco Home Healthcare, Inc.
    • Brookdale Senior Living Inc.
    • Sunrise Senior Living
    • Genesis HealthCare
    • EXTENDICARE.
    • Diversicare.
    • Home Instead, Inc.
    • Senior Services of America
    • Atria Senior Living, Inc
目次
Product Code: 978-1-68038-607-3

North America Home Healthcare Market Growth & Trends:

The North America home healthcare market size is expected to reach USD 285.05 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising aging human population, high disposable income for healthcare expenditure, and increasing rate of target diseases are some of the key factors driving growth. Predominance of chronic diseases, and increasing diagnosis expenditure is anticipated to boost growth.

Personalized medical assistance is a cost effective measure to control treatment expenditure and acts as a major driver for the industry. According to America's Health rankings, nearly 58 million adults aged 65 and older lived in the U.S. in 2022.

The home healthcare industry is anticipated to be majorly driven by the huge aging population volume which is highly prone to various diseases such as venous stasis ulcers, diabetic ulcers, and pressure ulcers. According to WHO, the global volume of population falls under the age group of 60 years and above has reached 841 million in 2014 and is expected to reach 2 billion by 2050. Therefore, rising global aging-population along with the statistics that approximately 70% of home healthcare patients belong to 65 years and above age group, is anticipated to fuel demand in the near future.

Wound care accounted for 65% of the global market revenue in 2014. Substantial demand for wound closures, wound care dressings, and wound cleanser has resulted in the dominance of the segment over the past few years and this trend is expected to continue over the forecast period. Wound infection is a key safety concern for medical professionals and patients, thus the market is anticipated to fuel the demand as it compelled to reduce the infection rates. Wound care products improve the overall health of patients affected from various disorders such as, diabetic ulcers, pressure ulcers and venous stasis ulcers, therefore creating strong need for these products in the industry.

Rising number of geriatric patients with growing awareness about personal safety and hygiene is further expected to intensify home healthcare service demand in North America. Baxter offers broad solutions to empower healthcare professionals to offer personalized care. It offers products for healthcare professionals for hospital care, primary care, kidney care, surgical care, nutritional care and others.

The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare. Different services such as nutritional support, nursing care, hospice & palliative, physician primary care, and others are offered by home healthcare services. The accurate diagnosis and medical treatment offered by skilled healthcare is attributing the segment growth. On the other hand, the equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.

The U.S. home healthcare market dominated the North America market with a share of 90.0% in 2023 due to advanced healthcare infrastructure. Large base of aging population, growing healthcare infrastructure and high purchasing power are some of the key factors driving growth. Moreover, favorable government initiatives aimed at controlling treatment expenditure by promoting home care services are anticipated to fuel growth. According to the PRB (Population Reference Bureau), at present, approximately 50 million citizens of North America are over 65 years and the number is projected to reach 89 million by 2050.

North America Home Healthcare Market Report Highlights:

  • The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare.
  • The equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.
  • The diabetes & kidney disorders segment accounted for the largest market share in 2023. According to American Diabetes Association, 38.4 million Americans were diagnosed with diabetes in 2021.
  • The mobility disorders segment is projected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Home Healthcare Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. North America Home Healthcare Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. North America Home Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Home Healthcare Market: Component Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Therapeutic
      • 4.3.2.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.1. Home Respiratory Equipment
          • 4.3.2.1.1.1. Home Respiratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.2. Insulin Delivery Market
          • 4.3.2.1.2.1. Insulin Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.3. Home IV Pumps
          • 4.3.2.1.3.1. Home IV Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.4. Home Dialysis Equipment
          • 4.3.2.1.4.1. Home Dialysis Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.5. Other Therapeutic Equipment
          • 4.3.2.1.5.1. Other Therapeutic Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Diagnostic
      • 4.3.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.1. Diabetic Care Unit
          • 4.3.3.1.1.1. Diabetic Care Unit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.2. BP Monitors
          • 4.3.3.1.2.1. BP Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.3. Multi Para Diagnostic Monitors
          • 4.3.3.1.3.1. Multi Para Diagnostic Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.4. Home Pregnancy and Fertility Kits
          • 4.3.3.1.4.1. Home Pregnancy and Fertility Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.5. Apnea and Sleep Monitors
          • 4.3.3.1.5.1. Apnea and Sleep Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.6. Holter Monitors
          • 4.3.3.1.6.1. Holter Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.7. Heart Rate Meters (include pacemakers)
          • 4.3.3.1.7.1. Heart Rate Meters (include pacemakers) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.8. Others
          • 4.3.3.1.8.1. Other Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Mobility Assist
      • 4.3.4.1. Mobility Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.1. Wheel Chair
          • 4.3.4.1.1.1. Wheel Chair Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.2. Home Medical Furniture
          • 4.3.4.1.2.1. Home Medical Furniture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.3. Walking Assist Devices
          • 4.3.4.1.3.1. Walking Assist Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Skilled Home Healthcare
      • 4.4.2.1. Skilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.1. Physician Primary Care
          • 4.4.2.1.1.1. Physician Primary Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.2. Nursing Care
          • 4.4.2.1.2.1. Nursing Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.3. Physical/Occupational/Speech Therapy
          • 4.4.2.1.3.1. Physical/Occupational/Speech Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.4. Nutritional Support
          • 4.4.2.1.4.1. Nutritional Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.5. Hospice & Palliative
          • 4.4.2.1.5.1. Hospice & Palliative Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.6. Other Skilled Nursing Services
          • 4.4.2.1.6.1. Other Skilled Nursing Se Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Unskilled Home Healthcare
      • 4.4.3.1. Unskilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Home Healthcare Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Home Healthcare Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular Disorder & Hypertension
    • 5.3.1. Cardiovascular Disorder & Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Diabetes & Kidney Disorders
    • 5.4.1. Equipment Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurological & Mental Disorders
    • 5.5.1. Neurological & Mental Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Respiratory Diseases & COPD
    • 5.6.1. Respiratory Diseases & COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Maternal Disorders
    • 5.7.1. Maternal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Mobility Disorders
    • 5.8.1. Mobility Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Cancer
    • 5.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Wound Care
    • 5.10.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Other Indications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Home Healthcare Market: Regional Estimates & Trend Analysis

  • 6.1. North America Home Healthcare Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Abbott
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Sunrise Medical
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. 3M
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Baxter
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Medtronic
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Cardinal Health
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. F. Hoffmann-La Roche Ltd
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Amedisys
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. ARKRAY, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. BD
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. OMRON Healthcare, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. GE Healthcare
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
    • 7.4.14. Medline Industries, Inc
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/ Strategic Initiatives
    • 7.4.15. Koninklijke Philips N.V.
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/ Strategic Initiatives
    • 7.4.16. Johnson & Johnson Services, Inc.
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/ Strategic Initiatives
    • 7.4.17. Acelity (3M)
      • 7.4.17.1. Participant's Overview
      • 7.4.17.2. Financial Performance
      • 7.4.17.3. Product Benchmarking
      • 7.4.17.4. Recent Developments/ Strategic Initiatives
    • 7.4.18. Teleflex Incorporated.
      • 7.4.18.1. Participant's Overview
      • 7.4.18.2. Financial Performance
      • 7.4.18.3. Product Benchmarking
      • 7.4.18.4. Recent Developments/ Strategic Initiatives
    • 7.4.19. Fresenius Kabi AG.
      • 7.4.19.1. Participant's Overview
      • 7.4.19.2. Financial Performance
      • 7.4.19.3. Product Benchmarking
      • 7.4.19.4. Recent Developments/ Strategic Initiatives
    • 7.4.20. Bayer AG
      • 7.4.20.1. Participant's Overview
      • 7.4.20.2. Financial Performance
      • 7.4.20.3. Product Benchmarking
      • 7.4.20.4. Recent Developments/ Strategic Initiatives
    • 7.4.21. GF Health Products, Inc.
      • 7.4.21.1. Participant's Overview
      • 7.4.21.2. Financial Performance
      • 7.4.21.3. Product Benchmarking
      • 7.4.21.4. Recent Developments/ Strategic Initiatives
    • 7.4.22. Knight Health Holdings, LLC
      • 7.4.22.1. Participant's Overview
      • 7.4.22.2. Financial Performance
      • 7.4.22.3. Product Benchmarking
      • 7.4.22.4. Recent Developments/ Strategic Initiatives
    • 7.4.23. NHC, National Healthcare Corporation
      • 7.4.23.1. Participant's Overview
      • 7.4.23.2. Financial Performance
      • 7.4.23.3. Product Benchmarking
      • 7.4.23.4. Recent Developments/ Strategic Initiatives
    • 7.4.24. Gentiva
      • 7.4.24.1. Participant's Overview
      • 7.4.24.2. Financial Performance
      • 7.4.24.3. Product Benchmarking
      • 7.4.24.4. Recent Developments/ Strategic Initiatives
    • 7.4.25. Medco Home Healthcare, Inc.
      • 7.4.25.1. Participant's Overview
      • 7.4.25.2. Financial Performance
      • 7.4.25.3. Product Benchmarking
      • 7.4.25.4. Recent Developments/ Strategic Initiatives
    • 7.4.26. Brookdale Senior Living Inc.
      • 7.4.26.1. Participant's Overview
      • 7.4.26.2. Financial Performance
      • 7.4.26.3. Product Benchmarking
      • 7.4.26.4. Recent Developments/ Strategic Initiatives
    • 7.4.27. Sunrise Senior Living
      • 7.4.27.1. Participant's Overview
      • 7.4.27.2. Financial Performance
      • 7.4.27.3. Product Benchmarking
      • 7.4.27.4. Recent Developments/ Strategic Initiatives
    • 7.4.28. Genesis HealthCare
      • 7.4.28.1. Participant's Overview
      • 7.4.28.2. Financial Performance
      • 7.4.28.3. Product Benchmarking
      • 7.4.28.4. Recent Developments/ Strategic Initiatives
    • 7.4.29. EXTENDICARE.
      • 7.4.29.1. Participant's Overview
      • 7.4.29.2. Financial Performance
      • 7.4.29.3. Product Benchmarking
      • 7.4.29.4. Recent Developments/ Strategic Initiatives
    • 7.4.30. Diversicare.
      • 7.4.30.1. Participant's Overview
      • 7.4.30.2. Financial Performance
      • 7.4.30.3. Product Benchmarking
      • 7.4.30.4. Recent Developments/ Strategic Initiatives
    • 7.4.31. Home Instead, Inc.
      • 7.4.31.1. Participant's Overview
      • 7.4.31.2. Financial Performance
      • 7.4.31.3. Product Benchmarking
      • 7.4.31.4. Recent Developments/ Strategic Initiatives
    • 7.4.32. Senior Services of America
      • 7.4.32.1. Participant's Overview
      • 7.4.32.2. Financial Performance
      • 7.4.32.3. Product Benchmarking
      • 7.4.32.4. Recent Developments/ Strategic Initiatives
    • 7.4.33. Atria Senior Living, Inc
      • 7.4.33.1. Participant's Overview
      • 7.4.33.2. Financial Performance
      • 7.4.33.3. Product Benchmarking
      • 7.4.33.4. Recent Developments/ Strategic Initiatives